1.35
price down icon4.26%   -0.06
after-market Handel nachbörslich: 1.35
loading

Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten

pulisher
04:32 AM

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

04:32 AM
pulisher
04:30 AM

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

04:30 AM
pulisher
Sep 18, 2024

Keeping an Eye on Tempest Therapeutics Inc (TPST) After Insider Trading Activity - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Tempest Further Strengthens Leadership Team with - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs - StockTitan

Sep 18, 2024
pulisher
Sep 18, 2024

Tempest Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Sep 18, 2024
pulisher
Sep 11, 2024

An Analysis of Tempest Therapeutics Inc (TPST)’s Potential Price Growth - Knox Daily

Sep 11, 2024
pulisher
Sep 05, 2024

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 05, 2024
pulisher
Sep 05, 2024

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 05, 2024
pulisher
Sep 05, 2024

Tempest Therapeutics Inc [TPST] Records 200-Day SMA of $3.1810 - Knox Daily

Sep 05, 2024
pulisher
Sep 05, 2024

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Sep 05, 2024
pulisher
Sep 04, 2024

Is Tempest Therapeutics Inc (TPST) worth investing in despite its undervalued state? - US Post News

Sep 04, 2024
pulisher
Sep 02, 2024

Scotiabank initates Tempest Therapeutics Inc (TPST) stock to a Sector outperform - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

Anchoring Your Portfolio: Is TPST Stock a Safe Harbor? - The InvestChronicle

Sep 02, 2024
pulisher
Sep 02, 2024

Ratios Uncovered: Breaking Down Tempest Therapeutics Inc (TPST)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 02, 2024
pulisher
Aug 29, 2024

You might want to take a look at Tempest Therapeutics Inc (TPST) now - SETE News

Aug 29, 2024
pulisher
Aug 28, 2024

The Attractiveness of Investing In Tempest Therapeutics Inc (TPST) is Growing - Knox Daily

Aug 28, 2024
pulisher
Aug 28, 2024

Investor’s Toolkit: Key Ratios for Assessing Tempest Therapeutics Inc (TPST)’s Performance - The Dwinnex

Aug 28, 2024
pulisher
Aug 27, 2024

How To Buy Tempest Therapeutics Inc. Stock Online in August 2024 - Traders Union

Aug 27, 2024
pulisher
Aug 26, 2024

Should investors be concerned about Tempest Therapeutics Inc (TPST)? - US Post News

Aug 26, 2024
pulisher
Aug 26, 2024

TPST’s 2023 Market Dance: Down -67.73% – Time to Invest? - The InvestChronicle

Aug 26, 2024
pulisher
Aug 23, 2024

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Aug 23, 2024
pulisher
Aug 23, 2024

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Aug 23, 2024
pulisher
Aug 23, 2024

Tempest Therapeutics Inc [TPST] Owner makes an insider purchase of 387,999 shares worth 0.43 million. - Knox Daily

Aug 23, 2024
pulisher
Aug 21, 2024

Tempest Therapeutics appoints new VP of Quality Assurance - Investing.com

Aug 21, 2024
pulisher
Aug 21, 2024

Check out these key findings about Tempest Therapeutics Inc (TPST) - SETE News

Aug 21, 2024
pulisher
Aug 21, 2024

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance - GlobeNewswire

Aug 21, 2024
pulisher
Aug 21, 2024

Market Momentum Report: Tempest Therapeutics Inc (TPST)’s Positive Close at 1.46 - The Dwinnex

Aug 21, 2024
pulisher
Aug 21, 2024

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance - StockTitan

Aug 21, 2024
pulisher
Aug 20, 2024

Tempest Therapeutics Inc [TPST] Investment Guide: What You Need to Know - Knoxdaily.com

Aug 20, 2024
pulisher
Aug 19, 2024

How should investors view Tempest Therapeutics Inc (TPST)? - US Post News

Aug 19, 2024
pulisher
Aug 18, 2024

Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday? - MSN

Aug 18, 2024
pulisher
Aug 17, 2024

Tempest Therapeutics (NASDAQ:TPST) Stock Rating Reaffirmed by HC Wainwright - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

Tempest Therapeutics Inc [TPST] Shares Rise 30.25% on Thursday - Knox Daily

Aug 16, 2024
pulisher
Aug 16, 2024

TPST’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Aug 16, 2024
pulisher
Aug 16, 2024

Scotiabank maintains a target on Tempest Therapeutics stock By Investing.com - Investing.com Canada

Aug 16, 2024
pulisher
Aug 15, 2024

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com Canada

Aug 15, 2024
pulisher
Aug 15, 2024

Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday? - Benzinga

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest stock jumps on positive FDA feedback (NASDAQ:TPST) - Seeking Alpha

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial - Investing.com

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com Australia

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Therapeutics Inc (TPST) Is Worth Accumulating At Current Levels - Stocks Register

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com India

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com UK

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Announces Successful End-of-Phase 2 Meeting with - GlobeNewswire

Aug 15, 2024
pulisher
Aug 15, 2024

Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma - StockTitan

Aug 15, 2024
pulisher
Aug 14, 2024

Its Stock Has Paid Off Big Time For Tempest Therapeutics Inc - SETE News

Aug 14, 2024
pulisher
Aug 14, 2024

Scotiabank slashes price target on Tempest Therapeutics Inc [TPST] – find out why. - The DBT News

Aug 14, 2024
pulisher
Aug 13, 2024

Tempest Flounders on News of Test Results - MSN

Aug 13, 2024
pulisher
Aug 13, 2024

Tempest Therapeutics, Inc. (NASDAQ:TPST) Major Shareholder Versant Venture Capital Vi, L. Sells 400,000 Shares of Stock - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Tempest Therapeutics, Inc. (NASDAQ:TPST) Major Shareholder Versant Venture Capital Vi, L. Sells 387,999 Shares - Defense World

Aug 13, 2024
pulisher
Aug 12, 2024

Versant entities sell Tempest Therapeutics shares worth over $967k - Investing.com

Aug 12, 2024
pulisher
Aug 12, 2024

Tempest Therapeutics Inc Inc. (TPST) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Aug 12, 2024
pulisher
Aug 12, 2024

Financial Health Report: Tempest Therapeutics Inc (TPST)’s Ratios Tell a Tale - The Dwinnex

Aug 12, 2024
pulisher
Aug 12, 2024

Was anything negative for Tempest Therapeutics Inc (TPST) stock last session? - US Post News

Aug 12, 2024
pulisher
Aug 09, 2024

TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 - MSN

Aug 09, 2024
pulisher
Aug 09, 2024

TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 - InvestorPlace

Aug 09, 2024
pulisher
Aug 09, 2024

A company insider recently bought 35,000 shares of Tempest Therapeutics Inc [TPST]. Should You Buy? - Knox Daily

Aug 09, 2024
pulisher
Aug 08, 2024

TPSTTempest Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com

Aug 08, 2024
pulisher
Aug 08, 2024

Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Aug 08, 2024
pulisher
Aug 08, 2024

Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update - wallstreet:online

Aug 08, 2024
pulisher
Aug 07, 2024

Virtu Financial LLC Acquires 11,689 Shares of Tempest Therapeutics, Inc. (NASDAQ:TPST) - Defense World

Aug 07, 2024
pulisher
Aug 06, 2024

A closer look at Tempest Therapeutics Inc (TPST)’s stock price trends - US Post News

Aug 06, 2024
pulisher
Aug 06, 2024

TPST Stock Update: Tempest Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Aug 06, 2024
$25.53
price down icon 3.59%
$24.39
price up icon 5.31%
$201.99
price up icon 1.71%
$65.69
price down icon 3.43%
$112.28
price down icon 0.20%
$533.00
price down icon 0.62%
Kapitalisierung:     |  Volumen (24h):